日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13
Share
Share - WeChat

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲一区二区三区在线 | 玖玖在线免费视频 | 九九九精品视频免费 | 亚洲欧美第一视频 | 日本精品二区 | 久久免费看 | 精品国产一区探花在线观看 | 成年网站在线观看 | 色在线视频网站 | 另类激情网 | 日本亚洲精品色婷婷在线影院 | 欧美在线黄 | 色综合成人网 | 一区二区三区国产在线 | 全部免费国产潢色一级 | 丁香六月啪 | 日本高清在线看片免费视频 | 亚洲欧美视频一区 | 日韩高清不卡 | 91高清国产视频 | 欧美日一区 | 一区二区日韩精品 | 蜜桃视频在线观看www社区 | 91麻豆精品国产91久久久更新时间 | 国产福利观看 | 一区二区三区四区国产精品视频 | 免费看毛片网 | 又黄又爽的成人免费网站 | 亚洲一区2区三区4区5区 | 亚欧免费视频一区二区三区 | 青青草成人免费视频在线 | 婷婷精品国产一区二区三区日韩 | 国产在线激情视频 | 日本aⅴ在线观看 | 亚洲免费网| 大蕉香蕉久久爱 | 国产精品久久人妻无码网站蜜臀 | 国产精品三级在线 | 亚洲另类天天更新影院在线观看 | 操操操操网 | 噜噜噜天天躁狠狠躁夜夜精品 |